Organogenesis Holdings Inc. (Nasdaq: ORGO) is a leading regenerative medicine company that develops, manufactures and commercializes innovative solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. On February 13th and 14th, management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference at the Cliff Lodge in Snowbird, UT. The participation includes 1×1 meetings on February 14th with no formal presentation.
The company offers a comprehensive portfolio of innovative regenerative products aimed at addressing patient needs across the continuum of care. Organogenesis Holdings Inc.’s main focus is on advanced wound care and surgical sports medicine markets. For more information about Organogenesis Holdings Inc., visit www.organogenesis.com.
For investor inquiries, please contact ICR Westwicke through Mike Piccinino, CFA at OrganoIR@westwicke.com. Press and media inquiries can be directed to Organogenesis at email@example.com